| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |









From the Departments of Biochemistry,* Periodontology,
Internal Medicine,
and Physiology,
Osaka Dental University, Osaka, Japan; the Division of Hematology and Immunology,¶ Department of Internal Medicine, Kanazawa Medical University, Kahoku-gun, Ishikawa, Japan; and the Departments of Surgery,|| Laboratory Medicine and Pathology,** Cancer Center, University of Minnesota, Minneapolis, Minnesota
Natural killer (NK) cells play a key role in inflammation and tumor regression through their ability to migrate into tissues. CXCL12 is a chemokine that promotes lymphocyte invasion and migration into tissues; however, the mechanism for this process remains incompletely understood. In this study, we show that CXCL12 significantly enhanced CD16+CD56+ human peripheral NK-cell invasion into type I collagen by the catalytic activity of matrix metalloproteinase-1 (MMP-1). Confocal immunofluorescence and co-immunoprecipitation studies suggest that MMP-1 colocalized with
2ß1 integrin on CXCL-12-stimulated NK-cell surface. The binding of pro-MMP-1 with
2ß1 integrin required activation of Gi-coupled pathway. However, the production of MMP-1 from CXCL12-stimulated NK cells was mediated by p38 and mitogen-activated or extracellular signal-regulation protein kinase kinase 1/2 in a manner independent of the Gi-coupled pathway. These results suggest that CXCL12/CXCR4 interaction transduces the two signaling pathways to promote NK-cell invasion, which stimulates pericellular degradation of extracellular matrix proteins by membrane-associated MMP-1. The mechanisms would thus play a role in facilitating lymphocyte trafficking and accumulation in tissues during physiological and pathological processes.
This article has been cited by other articles:
![]() |
S. Goda, H. Inoue, Y. Kaneshita, Y. Nagano, Y. T. Ikeo, J. Iida, and N. Domae Emdogain Stimulates Matrix Degradation by Osteoblasts J. Dent. Res., August 1, 2008; 87(8): 782 - 787. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |